The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FPT155-001: A phase Ia/Ib study of FPT155 (CD80-FC) in patients with advanced solid tumors.
 
Michael Millward
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer/EMD Serono; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
 
Hui Kong Gan
Consulting or Advisory Role - AbbVie
Speakers' Bureau - Bristol-Myers Squibb; Ignyta
Research Funding - AbbVie
Travel, Accommodations, Expenses - Ignyta
 
Anthony M. Joshua
Research Funding - Aptevo Therapeutics (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Lilly (Inst); Macrogenics (Inst); Mayne Pharma (Inst); Merck Sharp & Dohme (Inst); Roche/Genentech (Inst)
 
James Chun-Yen Kuo
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology; Zucero Therapeutics
 
Amy Prawira
Research Funding - Akeso Biopharma (Inst); Arcus Biosciences (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); CBT Pharmaceuticals (Inst); CStone Pharmaceuticals (Inst); Five Prime Therapeutics (Inst); Hutchison MediPharma (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Gary Edward Richardson
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); CBT Pharmaceuticals (Inst); Corvus Pharmaceuticals (Inst); Merck (Inst); Novotech (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst)
 
Susannah D. Barbee
Employment - Five Prime Therapeutics
Stock and Other Ownership Interests - Amgen; Bristol-Myers Squibb; CytomX Therapeutics; Five Prime Therapeutics
Patents, Royalties, Other Intellectual Property - Five Prime Therapeutics
 
Sandeep P. Inamdar
Employment - Acerta Pharma; Onyx
Stock and Other Ownership Interests - Amgen; Gilead Sciences; GlaxoSmithKline; Onyx
 
Kristen L. Pierce
Employment - Five Prime Therapeutics
Stock and Other Ownership Interests - Five Prime Therapeutics
Patents, Royalties, Other Intellectual Property - Five Prime Therapeutics
 
Mona Qureshi
Employment - Five Prime Therapeutics; Gilead Sciences
Stock and Other Ownership Interests - Five Prime Therapeutics; Gilead Sciences
 
Lisa Horvath
Employment - Connected Medical Solutions (I)
Leadership - Connected Medical Solutions (I)
Stock and Other Ownership Interests - Connected Medical Solutions (I)
Research Funding - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Cilag